CLNN
Clene Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.35
+4.82%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.46
- Revenue estimate
- $70.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$1.08
- EPS estimate
- -$0.37
- Revenue actual
- $90.0K
- Revenue estimate
- $61.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -62.4%
- Revenue beats (12Q)
- 6
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.37 | -$1.08 | Miss -193.48% | $90.0K |
| May 14, 2026 | -$0.50 | -$0.31 | Beat 38.00% | $15.0K |
| Mar 12, 2026 | -$0.58 | -$0.88 | Miss -52.39% | $77.0K |
| Nov 13, 2025 | -$0.60 | -$0.85 | Miss -41.67% | $15.0K |
| Aug 14, 2025 | -$0.49 | -$0.78 | Miss -59.18% | $27.0K |
| Mar 24, 2025 | -$1.21 | -$1.67 | Miss -38.02% | $91.0K |
| Mar 13, 2024 | -$1.40 | -$1.20 | Beat 14.29% | $170.0K |
| Aug 14, 2023 | -$2.60 | -$2.40 | Beat 7.69% | $269.0K |
| May 12, 2023 | -$3.20 | -$3.00 | Beat 6.25% | $107.0K |
| Mar 13, 2023 | -$3.00 | -$3.20 | Miss -6.67% | $234.0K |
| Aug 15, 2022 | -$4.20 | -$4.40 | Miss -4.76% | $35.0K |
| Mar 11, 2022 | -$3.60 | -$3.80 | Miss -5.56% | $199.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026